Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
indiana blog main
indiana top stories
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
3
×
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
allergy
anaphylaxis
andrew oxtoby
arena pharmaceuticals
avapritinib
blueprint medicines
boston
cancer drugs
What
drug
3
×
fda
3
×
approval
cancer
therapy
address
agency
aimmune
allergy
approved
approves
awarded
blueprint
carries
certain
designed
developed
eisai
flags
friday
genetic
higher
immunotherapy
incidence
late
latest
lorcaserin
loss
market
marketing
medicine
medicines
oral
pass
patients
peanut
post
pulls
ret
risks
Language
unset
3
×
Current search:
drug
×
unset
×
fda
×
" indiana top stories "
×
" san francisco top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy